These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 26449230

  • 21. Methotrexate treatment for sarcoid-associated panuveitis.
    Dev S, McCallum RM, Jaffe GJ.
    Ophthalmology; 1999 Jan; 106(1):111-8. PubMed ID: 9917790
    [Abstract] [Full Text] [Related]

  • 22. Multifocal choroiditis in patients with familial juvenile systemic granulomatosis.
    Latkany PA, Jabs DA, Smith JR, Rosenbaum JT, Tessler H, Schwab IR, Walton RC, Thorne JE, Maguire AM.
    Am J Ophthalmol; 2002 Dec; 134(6):897-904. PubMed ID: 12470760
    [Abstract] [Full Text] [Related]

  • 23. Unique Variant of NOD2 Pediatric Granulomatous Arthritis With Severe 1,25-Dihydroxyvitamin D-Mediated Hypercalcemia and Generalized Osteosclerosis.
    Whyte MP, Lim E, McAlister WH, Gottesman GS, Trinh L, Veis DJ, Bijanki VN, Boden MG, Nenninger A, Mumm S, Buchbinder D.
    J Bone Miner Res; 2018 Nov; 33(11):2071-2080. PubMed ID: 29933504
    [Abstract] [Full Text] [Related]

  • 24. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome).
    Carreño E, Guly CM, Chilov M, Hinchcliffe A, Arostegui JI, Lee RW, Dick AD, Ramanan AV.
    Acta Ophthalmol; 2015 May; 93(3):253-7. PubMed ID: 25209167
    [Abstract] [Full Text] [Related]

  • 25. Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.
    Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH.
    Am J Ophthalmol; 2018 Mar; 187():158-166. PubMed ID: 28887115
    [Abstract] [Full Text] [Related]

  • 26. Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Interlandi E, Leccese P, Olivieri I, Latanza L.
    Clin Exp Rheumatol; 2014 Mar; 32(4 Suppl 84):S58-62. PubMed ID: 25005224
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Ocular manifestations of Blau syndrome.
    Suresh S, Tsui E.
    Curr Opin Ophthalmol; 2020 Nov; 31(6):532-537. PubMed ID: 33009086
    [Abstract] [Full Text] [Related]

  • 29. Bilateral corneal infiltrates and uveitis in a pediatric patient with presumed ocular sarcoidosis.
    Güngör SG, Akova YA, Küçüködük A, Baskın E.
    Ocul Immunol Inflamm; 2013 Nov; 21(1):8-10. PubMed ID: 23323574
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinopathy (AZOOR) with adalimumab (Humira™).
    Neri P, Ricci F, Giovannini A, Arapi I, De Felici C, Cusumano A, Mariotti C.
    Int Ophthalmol; 2014 Apr; 34(2):359-64. PubMed ID: 23765682
    [Abstract] [Full Text] [Related]

  • 33. The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.
    Deitch I, Amer R, Tomkins-Netzer O, Habot-Wilner Z, Friling R, Neumann R, Kramer M.
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):801-808. PubMed ID: 29455252
    [Abstract] [Full Text] [Related]

  • 34. A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?
    Inoue Y, Kawaguchi Y, Shimojo N, Yamaguchi K, Morita Y, Nakano T, Arima T, Tomiita M, Kohno Y.
    Mod Rheumatol; 2013 Jul; 23(4):837-9. PubMed ID: 22821420
    [Abstract] [Full Text] [Related]

  • 35. Ocular Features in Chinese Patients with Blau Syndrome.
    Wu S, Zhong L, Sun Z, Zhu T, Song H, Sui R.
    Ocul Immunol Inflamm; 2020 Jul; 28(1):79-85. PubMed ID: 30806112
    [Abstract] [Full Text] [Related]

  • 36. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE.
    Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
    [Abstract] [Full Text] [Related]

  • 37. [Sarcoidosis and uveitis : An update].
    Garweg JG.
    Ophthalmologe; 2017 Jun; 114(6):525-533. PubMed ID: 27904945
    [Abstract] [Full Text] [Related]

  • 38. Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation.
    Milman N, Andersen CB, Hansen A, van Overeem Hansen T, Nielsen FC, Fledelius H, Ahrens P, Nielsen OH.
    APMIS; 2006 Dec; 114(12):912-9. PubMed ID: 17207093
    [Abstract] [Full Text] [Related]

  • 39. Blau syndrome with persistent fetal vasculature: a case report.
    Liu M, Zeng Y, Zhong J.
    J Med Case Rep; 2023 Jun 30; 17(1):301. PubMed ID: 37386644
    [Abstract] [Full Text] [Related]

  • 40. [Three cases--one diagnosis: ocular manifestations of sarcoidosis].
    Fieß A, Frisch I, Halstenberg S, Steinhorst U.
    Klin Monbl Augenheilkd; 2013 May 30; 230(5):530-5. PubMed ID: 23695850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.